Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Parkinson's Disease
Parkinson's Disease
Annovis Bio doses first subject in Phase III Parkinson’s trial
Clinical Trials Arena
Thu, 08/25/22 - 10:49 am
Annovis Bio
clinical trials
buntanetap
Parkinson's Disease
Inhibikase doses first subject in Phase IIa Parkinson’s treatment trial
Clinical Trials Arena
Wed, 08/24/22 - 10:38 am
Inhibikase Therapeutics
clinical trials
Parkinson's Disease
IkT-148009
Kyowa Kirin drops Nourianz follow-up KW-6356 for Parkinson’s
Pharmaforum
Mon, 07/18/22 - 09:53 am
Kyowa Kirin
KW-6356
clinical trials
Parkinson's Disease
Intercept, Annovis and Biohaven Advance Late Phase Trials
BioSpace
Mon, 07/11/22 - 12:00 am
Intercept Pharma NASH
Annovis
buntanetap
Parkinson's Disease
Biohaven
taldefgrobep alfa
SMA
Is AbbVie About To Get A New Blockbuster Drug?
Motley Fool
Mon, 06/27/22 - 10:31 am
AbbVie
Parkinson's Disease
ABBV-951
Trial site staff shortages, sluggish patient recruitment force Addex to scrap phase 3 Parkinson's study
Fierce Biotech
Fri, 06/17/22 - 09:53 am
Addex Therapeutics
dipraglurant
Parkinson's Disease
PD-LID
Startup gets green light to use Apple Watch to track Parkinson’s symptoms
Stat
Tue, 06/14/22 - 11:16 am
Medtech
FDA
Apple Watch
Parkinson's Disease
Rune Labs
StrivePD
Biogen bolsters pipeline again with Alectos deal
Pharmaforum
Tue, 06/7/22 - 09:56 am
Biogen
Parkinson's Disease
Alectos
AL01811
AbbVie asks FDA to approve Parkinson’s treatment
BioPharma Dive
Sun, 05/22/22 - 09:04 pm
AbbVie
FDA
Parkinson's Disease
carbidopa/levodopa
Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M
MedCity News
Mon, 05/9/22 - 11:22 pm
Aspen Neuro
Parkinson's Disease
stem cells
Bayer
cell therapy
PreciseDx AI diagnostic can detect early-stage Parkinson's
Pharmaforum
Thu, 04/21/22 - 10:39 am
digital health
diagnostics
Medtech
PreciseDX
artificial intelligence
Parkinson's Disease
AbbVie shreds alpha-synuclein Parkinson's pact on cusp of phase 2, thinning field led by Roche
Fierce Biotech
Wed, 04/20/22 - 10:59 am
AbbVie
Parkinson's Disease
alpha-synuclein
clinical trials
ABBV-0805
A Penn Parkinson's spinout goes dark as ex-FDA commish Hahn jumps off board
Endpoints
Thu, 04/7/22 - 10:19 am
Blackfynn
Parkinson's Disease
Stephen Hahn
With Positive Phase II Results, Cerevance Proves Concept in Parkinson’s
BioSpace
Fri, 04/1/22 - 10:30 am
Cerevance
Parkinson's Disease
clinical trials
CVN424
Sanofi makes $75M preclinical bet to join Roche, Novartis and more in congested Parkinson's field
Fierce Biotech
Wed, 01/12/22 - 11:19 pm
Sanofi
ABL Bio
Parkinson's Disease
ABL301
UCB Signs Up To $1.5 Bln Deal With Novartis To Co-develop Two Parkinson's Disease Drugs
NASDAQ
Thu, 12/2/21 - 10:39 am
Novartis
UCB Pharma
drug development
Parkinson's Disease
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models
Fierce Biotech
Fri, 11/5/21 - 09:49 am
Parkinson's Disease
Levodopa
gene therapy
Voyager Therapeutics
Bayer
AbbVie preps filings after ABBV-951 tops oral Parkinson’s drugs in trial
Pharmaforum
Sat, 10/30/21 - 10:48 pm
AbbVie
ABV-951
Parkinson's Disease
clinical trials
Positive Results in Hand, AbbVie Eyes Potential Approval for Parkinson’s Treatment
BioSpace
Thu, 10/28/21 - 10:16 pm
AbbVie
Parkinson's Disease
ABBV-951
clinical trials
Why Supernus' Acquisition of Adamas Is a Smart Move
Motley Fool
Thu, 10/21/21 - 09:30 am
Supernus
Adamas Pharmaceuticals
M&A
Parkinson's Disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »